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RESUMO 
 
Staphylococcus aureus resistente à meticilina (MRSA) é um importante patógeno de 
interesse humano. A resistência à meticilina é mediada pelos genes mecA e mecC e limita 
o uso de antimicrobianos.  Existem diferenças na expressão da resistência de acordo com 
o gene que a bactéria possui. Objetivo: propor a caracterização genotípica da resistência 
à meticilina em isolados de S. aureus. Metodologia: dezoito cepas de S. aureus foram 
obtidas no Laboratório de Microbiologia do Hospital Universitário Walter Cantídio. O 
teste de sensibilidade antimicrobiana foi realizado pelo método automatizado Vitek® 2. 
O presente estudo foi aprovado pelo Comitê de Ética em Pesquisa (CEP) do Hospital 
Universitário Walter Cantídio, com número 2.331.030. Resultados: o gene nuc foi 
detectado em 94,4% das cepas analisadas e a análise genotípica do mecA foi confirmada 
em 100% nas amostras que apresentaram resistência fenotípica à meticilina. A presença 
do gene mecC não foi detectada. Conclusão: todas as cepas que apresentaram resistência 
fenotípica à meticilina nos testes fenotípicos foram positivas para o gene mecA. 
 
Palavras chave: MRSA. nuc. mecA. mecC. 
 
ABSTRACT 
 
Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen of human 
interest. Methicillin resistance is mediated by mecA and mecC genes and limits the use 
of antimicrobials. There are differences in the expression of the resistance according to 
the gene of the bacterium. Objective: to propose the genotypic characterization of 
methicillin resistance in S. aureus isolates. Methodology: eighteen strains of S. aureus 
were obtained from the Laboratory of Microbiology at Walter Cantídio University 
Hospital. The antimicrobial susceptibility test was performed using the Vitek® 2 
automated method. Confirmation of the species was performed by detecting the nuc gene 
and investigating methicillin resistance using specific primers for the mecA and mecC 
genes carried out by the polymerase chain reaction (PCR).This study was approved by 
the Committee of Ethics in Research (CEP) of the University Hospital Walter Cantídio, 
with number 2.331.030. Results: the nuc gene was detected in 94.4% of strains analyzed 
and the genotypic analysis of the mecA confirmed in 100% in the samples that 
phenotypically presented resistance to methicillin. The presence of the mecC gene was 
not detected. Conclusion: all strains that phenotypically presented resistance to 
methicillin in the phenotypic tests were positive for the mecA gene. 
 
Keywords: MRSA. nuc. mecA. mecC. 
 
1  INTRODUCTION 
Staphylococcus aureus (S. aureus) although it is commonly colonizing several 
anatomical sites, is a pathogenic agent responsible for causing a wide diversity of 
Brazilian Journal of health Review 
 
 Braz. J. Hea. Rev., Curitiba, v. 2, n. 4, p.  3575-3584  jul./aug. 2019.   ISSN 2595-6825 
 
 
3577  
infections, such as cutaneous, soft tissue, bacteremia and endocarditis. It has great ease 
of hospital dissemination and antimicrobial resistance.1,2 In the early 1940s, prior to the 
introduction of penicillin for the treatment of S. aureus diseases, infections by this 
pathogen were often lethal. With the indiscriminate use of penicillin, it was soon observed 
the need for new drugs to treat resistant staphylococcal infections, later, boosting the 
development of semi-synthetic penicillins such as methicillin and oxacillin.3,4 
However, in the 1960s, the first isolates of methicillin-resistant S. aureus (MRSA) 
were detected in the United Kingdom. The starting point for the evolution of MRSA was 
the extent of the mecA gene, which encodes an exogenous penicillin binding protein 
(PBP), known as PBP2a or PBP2, which confers resistance to methicillin and cross-
resistance to other β-lactam drugs. MRSA strains are characterized by their β-lactam 
resistance phenotype, based on altered PBP. PBP2a is encoded by the mecA gene, being 
located along with its regulators, mecR1 and mecl, in a mobile genetic element called 
staphylococcal chromosomal cassette mec (SCCmec).4 
The homologous mecA gene (ecALGA2051) called mecC was first identified in 
Denmark and currently strains of S. aureus carrying the resistance genes are considered 
zoonotic agents.5,6,7 The mecC gene encod a transpeptidase enzyme with 63% identity to 
mecA-encoded PBP2a and is classified as SCCmec type XI, having structural similarities 
with other known SCCmec elements and is integrated in the same chromosomal locus. 
The binding between mecC and blaZLGA25 in a single genetic element may have enabled 
PBP2c to develop properties other than PBP2a. As for PBP2a, the expression of PBP2c 
is known to be regulated by mecI / mecR responsible for the induction of expression of 
this protein in the presence of β-lactamases.8,9,10 
Transcriptional, structural and / or functional differences are observed in strains 
harboring the mecA and mecC genes. In the present study, PBP2a and PBP2c gene 
products differ in their antimicrobial resistance levels and consequently have phenotypic 
differences that can be observed in clinical-laboratory tests.8,9,11 Failures are also verified 
in complementary assays for the detection of methicillin resistance using latex 
agglutination or PCR (polymerase chain reaction).6,11 
In view of the current problem with the increased incidence of methicillin-
resistant Staphylococcus aureus (MRSA) in the hospital environment, a better 
understanding of the molecular epidemiology of S. aureus strains is essential. Thus, the 
present study carried out the genotypic characterization of methicillin resistance of S. 
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aureus isolates from strains from the Laboratory of Microbiology of the Walter Cantídio 
University Hospital. 
 
2   MATERIAL AND METHODS 
2.1  BACTERIAL STRAINS 
Eighteen strains of Staphylococcus aureus resistant to methicillin belonging to the 
Microbiology Laboratory of Walter Cantídeo University Hospital, Fortaleza, Ceará State, 
Brazil, were analyzed.This study was approved by the Committee of Ethics in Research 
(CEP) of the University Hospital Walter Cantídio, with number of appreciation 
2.331.030. 
 
2.2  ANTIMICROBIAL SENSITIVITY TEST  
Bacterial identification and antimicrobial susceptibility testing were performed by 
the automated Vitek® 2 method according to the manufacturer's recommendations and 
interpreted according to the Clinical and Laboratory Standards Institute (CLSI) for the 
Minimum Inhibitory Concentration (MIC) test. The cut points for oxacillin are: sensitive 
≤ 2 μg / mL and resistant ≥ 4 μg / mL. 12 
 
2.3   DNA EXTRACTION 
From the growth in brain heart infusion incubated at 37°C for 18-24 h, the 
bacterial DNA extraction was performed according to Fang et al., 2003.13 Briefly, an 
aliquot (100 μl) of the extracted broth centrifuged at 20.800 rpm for 2 minutes, the 
supernatant removed carefully and the pellet suspended in 100 μl sterile distilled water. 
The suspension was heated at 95°C for 15 minutes. After centrifugation for 1 minute at 
20.800 rpm to sediment the debris, the clear supernatant was used as template DNA in 
PCR (Polymerase Chain Reaction). 
 
2.4  IDENTIFICATION OF THE NUC GENE  
For the genetic confirmation of the S. aureus species, the extracted DNA was 
subjected to PCR using primers nuc1 (5'-GCG ATT GAT GATGAT ACG GTT-3 ') and 
nuc 2 (5'-AGC CAA GCC TTG ACG AAC TAA AGC -3 ') according to Merlino et al., 
2002.14 The PCR reaction mix was made in a total volume of 20 μl, consisting of 10 μl 
Master Mix GoTaq®G2 Green Master Mix (Promega, USA), 7 μl of free nuclease water, 
1 μl of each primer at 20 μM , and 1 μl DNA at 50 ng / μl. The amplification program 
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consisted of 2 minutes at 94 ºC, 2 minutes at 55 ºC and 3 minutes at 72 ºC, for 40 cycles, 
with a 278 base pair (bp) gene product. Detection of the amplicon was performed on 1% 
agarose gel, then stained with ethidium bromide and visualized in UV translucent. 
Control of the specificity of the nuc gene for S. aureus was tested by two reference 
strains, the ATCC 25923 (S. aureus) positive control and ATCC 12228 (S. epidermidis) 
as negative control. 
 
2.5  DETECTION OF MECA AND MECC GENES 
Genotypic detection of methicillin resistance was done by detecting mecA genes 
using primers F5'-TGGTATGTGGAAGTTAGATTGGGAT-3 'and R5'-
CTAATCTCATATGTGTTCCTGTATTGGC-3', according to Merlino et al (2002)14 and 
mecC or mecALGA251 using primers F5 '-CATTAAAATCAGAGCGAGGC-3' and R5'-
TGGCTGAACCCATTTTTGAT-3 ', as used by Paterson et al. (2012)15 resulting in 533 
bp and 188 bp gene products, respectively. The specificity of each primer pair was 
confirmed in preliminary experiments with the identity of the confirmed product by 
sequencing. Detection of the mecA and mecC genes followed the same protocol as the 
nuc gene. 
 
3    RESULTS 
The specificity of the nuc gene was observed by the genotyping of the reference 
strains, ATCC 25923 and ATCC 12228, not being amplified in the S. epidermidis species 
used as negative control, thus confirming the specificity for S. aureus species. Of the 18 
samples tested, 94.4% presented positivity for the nuc gene (Figure 1). 
Phenotypic analysis of methicillin resistance indicated that 22.22% of the strains 
were resistant, with MIC ≥ 4 μg / mL, and 77.77% sensitive to the drug, ranging from 
0.25 to 0.5 μg / mL. Genotypic detection of mecA was confirmed in 100% of methicillin-
resistant strains, therefore the detection of the mecC gene was not performed, since 
resistance was associated with the presence of the mecA gene (Figure 2). Methicillin-
sensitive strains were randomly selected for mecA gene research to ensure specificity of 
the reaction. In all samples the presence of the mecC gene was not detected. 
 
4   DISCUSSION 
The use of the nuc gene for detection and confirmation of the S. aureus species 
was positive in 94.4% of the samples tested. The species S. aureus, S. hyicus and S. 
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intermedius are coagulase producers and can be confused when using the phenotypic 
identification methods.16 Immunoenzymatic tests performed by Brakstad et al. (1992)17 
found specificity of anti-termonuclease antibodies for S. aureus and proposed a target for 
adequate identification of S. aureus strains. Later, some authors have suggested the use 
of molecular biology to differentiate these pathogens through the identification of the nuc 
gene, a thermostatic nuclease encoder, found in coagulase-producing strains.14,18 
 In the present work, we have investigated the specific properties of the nuc gene 
for identification of S. aureus.14,16,17 In our study the amplification of the nuc gene 
occurred only in the positive control, strain ATCC 25923 confirming the specificity of 
the primer used.9,14 The strain that does not hear amplification of the gene must belong to 
another species coagulase producing, needing additional tests for better 
characterization.14 
All strains that phenotypically presented resistance to methicillin in the 
phenotypic tests were positive for the mecA gene. There was agreement of 100% of 
phenotypic and genotypic resistance. The molecular biology assay has high sensitivity 
and specificity in the confirmation of the mecA gene, considering the best way to detect 
the gene.14,15 
In our study, no sample had the presence of the mecC gene in MRSA strains, 
probably because our total number of samples was small. Therefore, it is a limitation of 
our work. Other studies conducted in Brazil, investigating several MRSA samples, 
attributed methicillin resistance to the mecA gene.19,20 Thus, we emphasize the 
importance of investigating if in Brazil there is circulation of the gene mecC. The mecC 
gene was first identified in Denmark, and has been reported in England, Germany, the 
Netherlands, France, Ireland, Norway and Sweden.21 
Epidemiological studies that evaluate the genetic profile of genes mediating 
MRSA resistance allow a better identification of characteristic patterns in each region 
studied, since these data are very variable with each location searched. 
 
5   CONCLUSION  
In conclusion, all strains that phenotypically presented resistance to methicillin in 
the phenotypic tests were positive for the mecA gene. 
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APPENDIX 
Figure 1: PCR analysis for mecA and nuc genes in MRSA. The arrows indicate the amplicons of 533 bp 
and 278 bp respectively. 
 
Figure 2: PCR analysis for mecA and nuc genes in MRSA. The arrows indicate the amplicons of 533 bp 
and 278 bp respectively.  
 
 
 
 
 
 
 
 
 
 
Brazilian Journal of health Review 
 
 Braz. J. Hea. Rev., Curitiba, v. 2, n. 4, p.  3575-3584  jul./aug. 2019.   ISSN 2595-6825 
 
 
3582  
REFERENCES 
 
1. HUANG L, ZHANG R, HU Y, ZHOU H, CAO J, LV H, et al. Epidemiology and risk 
factors of methicillin-resistant Staphylococcus aureus and vancomycin-
resistant enterococci infections in Zhejiang China from 2015 to 2017. Antimicrobial 
Resistance & Infection Control, v.8, p. 90, 2019. 
2.  LIM WW, WU P, BOND HS, WONG JY, NI K, SETO H, et al. Determinants of 
methicillin-resistant Staphylococcus aureus (MRSA) prevalence in the Asia-Pacific 
region: A systematic review and meta-analysis. Journal of Global Antimicrobial 
Resistance, v. 16, p. 17-27, 2019. 
3.FIGUEIREDO  AMS, FERREIRA FA. The multifaceted resources and microevolution 
of the successful human and animal pathogen methicillin-resistant Staphylococcus 
aureus. Memórias do Instituto Oswaldo Cruz, v. 109, n. 3, p. 265-278, 2014. 
4.VESTERGAARD MD, FREES & INGMER H. Antibiotic Resistance and 
the MRSA Problem. Microbiology Spectrum, v. 7, n. 2, p. GPP3-0057, 2019. 
5. ASIIMWE BB, BALDAN R, TROVATO A, CIRILLO DM. Molecular epidemiology 
of Panton-Valentine Leukocidin-positive community-acquired methicillin resistant 
Staphylococcus aureus isolates in pastoral communities of rural south western 
Uganda. BMC Infectious Diseases, v. 17, n. 1, p. 24, 2017. 
6. HARRISON EM, PATERSON GK, HOLDEN MTG, LARSEN J, STEGGER M, 
LARSEN AR, et al. Whole genome sequencing identifies zoonotic transmission of 
MRSA isolates with the novel mecA homologue mecC. EMBO Molecular Medicine, v. 
5, n. 4, p. 509-515, 2013. 
7. SHORE AC, DEASY EC, SLICKERS P, BRENNAN G, O’CONNELL B, 
MONECKE S, et al. Detection of staphylococcal cassette chromosome mec type XI 
carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical 
isolates of clonal complex 130 methicillin-resistant Staphylococcus 
aureus. Antimicrobial Agents and Chemotherapy, v. 55, n. 8, p. 3765-3773, 2011. 
8. BA X, HARRISON EM, LOVERING AL, GLEADALL N, ZADOKS R, PARKHILL 
J, et al. Old drugs To treat resistant bugs: Methicillin-resistant Staphylococcus aureus 
isolates with mecC are susceptible to a combination of penicillin and clavulanic 
acid. Antimicrobial Agents and Chemotherapy, v. 59, n. 12, p. 7396-7404, 2015. 
9. BALLHAUSEN B, KRIEGESKORTE A, SCHLEIMER N, PETERS G, BECKER K. 
The mecA homolog mecC confers resistance against β-lactams in Staphylococcus aureus 
Brazilian Journal of health Review 
 
 Braz. J. Hea. Rev., Curitiba, v. 2, n. 4, p.  3575-3584  jul./aug. 2019.   ISSN 2595-6825 
 
 
3583  
irrespective of the genetic strain background. Antimicrobial Agents and 
Chemotherapy, v. 58, n. 7, p. 3791-3798, 2014. 
10. BECKER K, DENIS O, ROISIN S, MELLMANN A, IDELEVICH EA, KNAACK 
D, et al.  Detection of mecA- and mecC-Positive Methicillin-Resistant Staphylococcus 
aureus (MRSA) Isolates by the New Xpert MRSA Gen 3 PCR Assay. Journal of Clinical 
Microbiology, v. 54, n. 1, p. 180-184, 2016. 
11. GOUDARZI M., ESLAMI G, REZAEE R, HEIDARY M, KHOSHNOOD S, 
SAJADI NIA, R. Clonal dissemination of Staphylococcus aureus isolates causing 
nosocomial infections, Tehran, Iran. Iranian Journal of Basical Medical Sciences, v. 
22, p. 238-245, 2019. 
12. ZURITA J, MEJIA C, GUZMÁN-BLANCO M. Diagnóstico e teste de sensibilidade 
para Staphylococcus aureus resistente à meticilina na América Latina. Brazilian Journal 
Infectious Disease, v. 14, n. 2, 2010. 
13. FANG H, HEDIN G. Rapid screening and identification of methicillin-resistant 
Staphylococcus aureus from clinical samples by selective-broth and real-time PCR 
assay. Journal of Clinical Microbiology, v. 41, n. 7, p. 2894-2899, 2003. 
14. MERLINO J, WATSON J, ROSE B, BEARD-PEGLER M, GOTTLIEB T, 
BRADBURY R, et al. Detection and expression of methicillin/oxacillin resistance in 
multidrug-resistant and non-multidrug-resistant Staphylococcus aureus in Central 
Sydney, Australia. Journal of Antimicrobial Chemotherapy, v. 49, n. 5, p. 793-801, 
2002. 
15. PATERSON GK, LARSEN AR, ROBB A, EDWARDS GE, PENNYCOTT TW, 
FOSTER G, et al. The newly described mecA homologue, mecALGA251, is present in 
methicillin-resistant Staphylococcus aureus isolates from a diverse range of host 
species. Journal of Antimicrobial Chemotherapy, v. 67, n. 12, p. 2809-2813, 2012. 
16. GANDRA EA, FERNANDEZ MA, SILVA JA, SILVA WP. Standardization of a 
multiplex PCR for the identification of coagulase-positive Staphylococcus. Food Science 
and Technology (Campinas), v. 31, n. 4, p. 946-949, 2011. 
17. BRAKSTAD OG, AASBAKK K, MAELAND JA. Detection of Staphylococcus 
aureus by polymerase chain reaction amplification of the nuc gene. Journal of Clinical 
Microbiology, v. 30, n. 7, p. 1654-1660, 1992. 
18. YANG Y, DONG S, WU  Y, YU K, JUN LY, WEI H, et al. Detection of 
Staphylococcus aureus in dairy products by polymerase chain reaction 
assay. Agricultural Sciences in China, v. 6, n. 7, p. 857-862, 2007. 
Brazilian Journal of health Review 
 
 Braz. J. Hea. Rev., Curitiba, v. 2, n. 4, p.  3575-3584  jul./aug. 2019.   ISSN 2595-6825 
 
 
3584  
19. BATISTA, Bruna Gerardon. Caracterização Molecular de Isolados Clínicos de 
Staphylococcus aureus Resistentes à Meticilina (MRSA) Isolados em um Hospital 
do Sul do Brasil. 2015. 
20. OKADO, Jessica Baleiro. Análise epidemiológica molecular de Staphylococcus 
aureus resistentes à meticilina (MRSA) isolados de colonização de pacientes HIV 
positivos internados em uma instituição de saúde da cidade de Ribeirão Preto. Tese 
de Doutorado. Universidade de São Paulo. 2014. 
21. BECKER K, LARSEN AR, SKOV RL, PATERSON GK, HOLMES MA, SABAT 
AJ, et al. Evaluation of a modular multiplex-PCR methicillin-resistant Staphylococcus 
aureus detection assay adapted for mecC detection. Journal of Clinical Microbiology, 
v. 51, n. 6, p. 1917-1919, 2013. 
 
